RNA Cap Modification Emerges as a Switch That Governs Tumor Response to Radiotherapy
A new study shows that the RNA cap-modifying enzyme PCIF1 drives tumor growth and radioresistance, and that removing its m6Am ...
A new study shows that the RNA cap-modifying enzyme PCIF1 drives tumor growth and radioresistance, and that removing its m6Am ...
A new mouse study shows that activating the cGAS-STING immune pathway early after spinal cord injury and inhibiting it later ...
Activating the antioxidant regulator NRF2 suppresses STING-driven inflammation in obese fat tissue, but the effect differs sharply between visceral and ...
Researchers have built a cancer-cell-membrane-coated manganese dioxide nanosheet that delivers the immune adjuvant R848 directly to tumors, relieving hypoxia and ...
A new review argues that antibody–drug conjugates act as immune modulators through immunogenic cell death, Fc-mediated effector functions and tumour ...
A new review synthesizes clinical trial evidence showing that combining radiotherapy with immune checkpoint inhibitors can dramatically boost response rates ...
A cross-sectional study of sixty older people living with HIV finds that common hypomorphic variants of the STING1/TMEM173 gene are ...
A new review outlines how combining PARP inhibitors with immune checkpoint inhibitors can convert immunologically cold ovarian tumors into hot ...
A comprehensive atlas of STING mutations consolidates genetic, structural, and clinical data to clarify how variants drive autoinflammation, immunodeficiency, and ...
A new study published in Nature Aging reports that mice lacking the enzyme cGAS develop signs of premature aging, accompanied ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine